This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Marsh & McLennan (MMC) Hits 52-Week High on Solid Q3 Results
by Zacks Equity Research
Shares of Marsh & McLennan (MMC) scale a 52-week high on Nov 9, backed by a solid third-quarter earnings performance.
EHealth (EHTH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 8th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th
EHealth (EHTH) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher Expands in Hispanic Market With Pronto
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Pronto to help it consolidate its position as one of the largest MGAs in the country and enhance its Risk Placement Services' offerings.
Can The Uptrend Continue for eHealth (EHTH)?
by Zacks Equity Research
Investors certainly have to be happy with eHealth, Inc. (EHTH) and its short term performance
eHealth (EHTH) Q4 Loss Narrower Than Expected, View Revised
by Zacks Equity Research
eHealth???s (EHTH) Q4 reflects soft performance at Individual, Family and Small Business segment and higher costs weighing on the stock.
eHealth (EHTH) Expects to Incur Net Loss in Q4, Shares Down
by Zacks Equity Research
eHealth's (EHTH) submitted applications for all its Medicare products increased 10% year over year in 2017 but failed to meet management's growth expectation in high-teens.
Avoid These Stocks at Highs While Earnings Plummet
by David Bartosiak
These five stocks are near 52-week highs while they have experienced negative earnings estimate revisions
eHealth to Provide Square's Clients With Insurance Solutions
by Zacks Equity Research
eHealth collaborates with Square to provide health insurance solutions to the payment vendor's clients and customers.
eHealth (EHTH) Q2 Loss Wider Than Expected, '17 View Intact
by Zacks Equity Research
eHealth's (EHTH) second-quarter results reflect lower revenues, higher expenses and lower memberships.
Arthur J. Gallagher & Co. Ramps Up Expansion with Buyouts
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) has announced to take over Armstrong/Robitaille/Riegle, Inc., and Ann Arbor Business Advisors, LLC. in Michigan and Total Reward Group in England.
Arthur J. Gallagher Buys Williams-Manny Insurance Group
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) recently acquired Williams-Manny Insurance Group to add capabilities to its compelling portfolio.
Why You Should Hold Willis Towers (WLTW) Stock for Now
by Zacks Equity Research
Shares of Willis Towers Watson plc (WLTW) have outperformed the Zacks categorized Insurance Brokerage industry, year to date. The estimates have also been revised upward over the last 30 days.
Why Should You Retain Arthur J. Gallagher (AJG) In Portfolio?
by Zacks Equity Research
We believe Arthur J. Gallagher's (AJG) solid organic and inorganic background, strong balance sheet and effective capital deployment bodes well for long-term growth.
Here's Why Should Retain XL Group (XL) in Your Portfolio
by Zacks Equity Research
Shares of XL Group plc (XL) have outperformed the Zacks categorized Property and Casualty Insurance industry, year to date. Shares gained 13.69% compared with 2.0% increase by the industry.
Five Strong Buys Bucking Market Trends
by David Bartosiak
Yesterday???s face-melting selloff certainly put plenty of stocks under pressure but some broke out to the upside
eHealth (EHTH) Shares March Higher, Can It Continue?
by Zacks Equity Research
eHealth, Inc. (EHTH) has been on the move lately as the stock has risen by 63.9% in the past four weeks, and it is currently trading well above its 20-Day SMA
Arthur J. Gallagher Buys Strong Financial, Grows in Nebraska
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) recently acquired Strong Financial Resources, Inc. to expand its presence in Nebraska.
New Strong Sell Stocks for March 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day
Bear of the Day: eHealth (EHTH)
by Kevin Cook
While the imminent demise of Obamacare could offer a positive catalyst, right now the outlook is headed south
New Strong Sell Stocks for February 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
U.S. Insurance Stock Outlook - May 2016
by Kalyan Nandy
Although the only rate hike (so far) doesn't bring much immediate relief for insurers, the Fed will hike rates further, either in predictable fashion or not.
U.S. Insurance Stock Outlook - May 2016
by Kalyan Nandy
Although the only rate hike (so far) doesn't bring much immediate relief for insurers, the Fed will hike rates further, either in predictable fashion or not.